ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma.

Sundar Jagannath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.